CLLS
Cellectis SA Sponsored ADR · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website cellectis.com
- Employees(FY) 231
- ISIN US15117K1034
Performance
-7.72%
1W
+20.08%
1M
+3.46%
3M
+14.12%
6M
-2.92%
YTD
+66.11%
1Y
Profile
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALLO-501A to treat relapsed or refractory for non-hodgkin lymphoma (NHL); and ALLO-715 for the treatment of multiple myeloma. It also develops UCART22 to treat B-cell acute lymphoblastic leukemia; UCARTCS1 and ALLO-605 for the treatment of multiple myeloma; ALLO-316 for renal cell carcinoma; UCART123 for the treatment of acute myeloid leukemia; and UCART 20x22 for relapsed or refractory B-Cell NHL. The company has strategic alliances with Allogene Therapeutics, Inc. and Les Laboratoires Servier; research collaboration and exclusive license agreement with Iovance Biotherapeutics; and collaboration and license agreement with Cytovia, as well as a collaboration agreement with AstraZeneca to develop novel cell and gene therapy candidate products. Cellectis S.A. was founded in 1999 and is headquartered in Paris, France.
Technical Analysis of CLLS 2024-05-10
Overview:
In analyzing the technical indicators for CLLS over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day Moving Average (MA) has been consistently above the c...
Recent News & Updates
- 2023-10-03 04:30
- 2023-10-02 21:55
- 2023-09-27 04:30
- 2023-09-05 04:30
- 2023-08-07 04:30
- 2023-08-03 04:30
- 2023-08-01 04:30
- 2023-07-27 04:30
- 2023-07-12 04:30
- 2023-06-28 04:30
- 2023-06-13 04:30
- 2023-06-09 04:30
- 2023-06-05 04:30
- 2023-05-31 04:50
- 2023-05-17 04:30
- 2023-05-11 13:30
- 2023-05-10 22:20
- 2023-05-10 04:30
- 2023-05-04 04:30
- 2023-05-02 04:35
- 2023-04-27 04:30
- 2023-04-24 04:30
- 2023-04-16 14:00
- 2023-04-12 04:30
- 2023-04-11 04:30
- 2023-04-04 04:30
- 2023-03-15 05:02
- 2023-03-14 05:00
- 2023-03-08 03:45
- 2023-03-06 03:30